These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23446309)

  • 1. Volatile breath biomarkers for patient monitoring during haemodialysis.
    Goerl T; Kischkel S; Sawacki A; Fuchs P; Miekisch W; Schubert JK
    J Breath Res; 2013 Mar; 7(1):017116. PubMed ID: 23446309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath analysis in patients with end-stage renal disease: effect of haemodialysis.
    Rolla G; Bruno M; Bommarito L; Heffler E; Ferrero N; Petrarulo M; Bagnis C; Bugiani M; Guida G
    Eur J Clin Invest; 2008 Oct; 38(10):728-33. PubMed ID: 18837798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD.
    Lee HJ; Pahl MV; Vaziri ND; Blake DR
    J Ren Nutr; 2012 May; 22(3):357-64. PubMed ID: 22100775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study.
    Assady S; Marom O; Hemli M; Ionescu R; Jeries R; Tisch U; Abassi Z; Haick H
    Nanomedicine (Lond); 2014 May; 9(7):1035-45. PubMed ID: 24066923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study.
    Pabst F; Miekisch W; Fuchs P; Kischkel S; Schubert JK
    J Cardiothorac Surg; 2007 Sep; 2():37. PubMed ID: 17877828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease.
    Schönermarck U; Dengler C; Gmeinwieser A; Praun S; Schelling G; Fischereder M; Boulesteix AL; Dolch ME
    Clin Nephrol; 2016 Sep; 86(9):132-40. PubMed ID: 27443565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.
    Mochalski P; King J; Haas M; Unterkofler K; Amann A; Mayer G
    BMC Nephrol; 2014 Mar; 15():43. PubMed ID: 24607025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective haemodialysis increases exhaled isoprene.
    Lirk P; Bodrogi F; Raifer H; Greiner K; Ulmer H; Rieder J
    Nephrol Dial Transplant; 2003 May; 18(5):937-41. PubMed ID: 12686668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath analysis as promising indicator of hemodialysis efficiency.
    Grabowska-Polanowska B; Miarka P; Skowron M; Chmiel G; Pietrzycka A; Śliwka I
    Clin Exp Nephrol; 2019 Feb; 23(2):251-257. PubMed ID: 30121801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring breath during oral glucose tolerance tests.
    Ghimenti S; Tabucchi S; Lomonaco T; Di Francesco F; Fuoco R; Onor M; Lenzi S; Trivella MG
    J Breath Res; 2013 Mar; 7(1):017115. PubMed ID: 23446273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New opportunities of renal diseases diagnostics using gas chromatography].
    Grabowska-Polanowska B; Faber J; Skowron M; Miarka P; Pietrzycka A; Zagrodzki P; Sliwka I; Sutowicz W; Stepniewski M
    Przegl Lek; 2012; 69(3):91-7. PubMed ID: 22764649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis.
    Barker M; Hengst M; Schmid J; Buers HJ; Mittermaier B; Klemp D; Koppmann R
    Eur Respir J; 2006 May; 27(5):929-36. PubMed ID: 16455833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset, time course, and persistence of increased haemodialysis-induced breath isoprene emission.
    Trovarelli G; Brunori F; De Medio GE; Timio M; Lippi G; Pelli MA; Capodicasa E
    Nephron; 2001 May; 88(1):44-7. PubMed ID: 11340350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.
    Obermeier J; Trefz P; Happ J; Schubert JK; Staude H; Fischer DC; Miekisch W
    PLoS One; 2017; 12(6):e0178745. PubMed ID: 28570715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus?
    Smith D; Spaněl P; Fryer AA; Hanna F; Ferns GA
    J Breath Res; 2011 Jun; 5(2):022001. PubMed ID: 21512208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath.
    Spaněl P; Dryahina K; Smith D
    J Breath Res; 2013 Mar; 7(1):017106. PubMed ID: 23445832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques.
    Neri G; Lacquaniti A; Rizzo G; Donato N; Latino M; Buemi M
    Nephrol Dial Transplant; 2012 Jul; 27(7):2945-52. PubMed ID: 22492831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.